Microbiology Testing Market Size to grow by USD 3012.8 million between 2023-2027
The Microbiology Testing Market is segmented by Product (Consumable and Instruments), End-user (Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)). As per the Global Forecast research report 2023-2027 published by Technavio, the market size is estimated to grow by USD 3012.8 million, at a CAGR of 9.98% during the forecast period. There are several companies that are contributing to the market as per this report. Increasing applications of microorganisms .
By Product, the Consumable segment is projected to dominate the market size in 2024
The Microbiology Testing Market encompasses test kits, assays, and reagents essential for quantifying infectious diseases. This segment holds substantial market growth potential due to the continuous demand for a diverse array of PCR consumables for various testing applications. Reagents and buffers, among other consumables, are frequently utilized by end-users for conducting tests and experiments. The versatility of applications necessitates the use of various reagents, thereby creating a significant opportunity for manufacturers of PCR consumables to offer a comprehensive range of products catering to the diverse testing requirements of clients.
For insights on company offerings- Request a sample report!
By End-user, Hospitals and diagnostic laboratories segment is expected to hold the largest market size for the year 2024
Hospital-affiliated laboratories serve as essential extensions of healthcare institutions, offering anatomic and clinical testing services. Anatomic testing encompasses surgical pathology, cytopathology, and autopsy, while clinical testing involves laboratory medicine. Diagnostic laboratories, which can be private or commercial, execute high-volume and specialty testing, primarily sourced from doctors, hospitals, and long-term care facilities. In 2022, hospitals and diagnostic laboratories held the significant market share in microbiology testing, fueled by the escalating demand from critically ill patients post-pandemic and the expanding geriatric population worldwide. These factors will continue to propel the growth of the hospitals and diagnostic laboratories segment within the global microbiology testing market throughout the forecast period.
Why is North America forecasted to hold the largest regional market size in 2024?
In the global microbiology testing market, North America emerged as the largest revenue generator in 2022, with the United States being the primary contributor. The region's market growth can be attributed to the significant investment in drug and vaccine discovery and development, advanced biotechnology and pharmaceutical research, and the presence of numerous microbiology testing product vendors. The US market is spearheaded by prominent pharmaceutical companies, such as Novartis and Pfizer, that prioritize Research and Development (R&D) for drug development and disease diagnosis, necessitating extensive microbiology testing.
To access the valuable insights - Download the Free Sample Report
Research Analysis Overview
The Microbiology Testing Market encompasses a wide range of diagnostic tests used for identifying the causative organisms or etiologic agents of various infectious diseases, including bacteria, fungi, parasites, and viruses. Companies like Bruker play a significant role in this market by providing advanced microbiology instruments for antimicrobial susceptibility testing and early disease diagnosis. UNAIDS and other healthcare organizations emphasize the importance of accurate and timely microbiology testing services for effective patient management, particularly in the case of HIV and other infectious diseases. However, laboratory reimbursement issues and staffing shortages pose challenges to the market. Private-public funding and healthcare expenditure are crucial factors influencing the demand for diagnostic tests and microbiology instruments. Clinical microbiology laboratories rely on various testing supplies, extraction reagents, and trained technologists to ensure accurate results. PubMed Central and other scientific databases provide valuable information on the latest research in microbiology testing, including advances in diagnostics, healthcare infrastructure, food safety, and pharmaceutical research. The market for microbiology testing services is vast and diverse, serving various industries and applications, from healthcare to research and development.
Market Research Overview
According to Technavio, the global microbiology testing market is a significant segment of the expansive life science tools and services market. This market encompasses organizations involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, accessories, and consumables. These tools and services are utilized in the pharmaceutical and biotechnology industries for the production of new drugs and in laboratories for disease diagnosis. Additionally, the market includes life sciences-related services, including contract research, contract manufacturing, and contract sales. The global healthcare market size, as calculated by Technavio, represents the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. - The Microbiology Testing Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
